The 2011 Enterovirus Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

News provided by

Nov 16, 2011, 11:20 ET

NEW YORK, Nov. 16, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics title='The 2011 Enterovirus Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country'>The 2011 Enterovirus Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country

http://www.reportlinker.com/p0444713/The-2011-Enterovirus-Diagnostics-Market-US-Europe-Japan

Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

The report presents a detailed analysis of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

- Hospitals

- Commercial/Private Labs

- Physician Offices

- Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Enterovirus tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 202 pages and 9 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Background

B. Diagnostic Tests

Viral Isolation and Identification

Antibody Tests

C. Vaccines and Drugs

D. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

Polymerase Chain Reaction

Robotics

Temperature Cyclers

PCR Variations

Immuno-PCR

QC-PCR

DAP-PCR

Ligase Chain Reaction

Branched DNA

Q-Beta Replicase

Nucleic-Acid Sequence-Based

Strand Displacement Activation

Self-Sustained Sequence Replicase

2. Monoclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays (EIA)

Overview

ELISA

Dot Immunobinding Assays

Capillary Immunoassays

Particle-Membrane Capture Immunoassays

Enzyme Amplification

c. Fluorescent Immunoassays

Fluorescence Polarization

Time-Resolved Pulse Fluorescence

d. Luminescence

Chemiluminescence

Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Differential Light Scattering

5. Microcomputers and Automation

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. MRI

11. Gel Microdroplets

12. Other

III. France: Test Volume and Diagnostics Sales Forecast by Market Segment

IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment

V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment

VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment

VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment

VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

X. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

XI. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

XII. Competitive Assessments

Abbott

Affymetrix

Applera

Beckman Coulter

Becton Dickinson

Binding Site

Biomerica

Biokit

bioMerieux

Bio-Rad

Biotrol

Biosite

Biotest

Caliper Technologies

Cepheid

Chemicon

Daiichi

DiaSorin

Diagast

Diamedix

Digene

Eiken

Enzo Biochem

Fujirebio

GenBio

Gene-Tec

Hemagen

Immunetics

Innogenetics

Inverness

J&J

Meridian

Nanogen

Nissui

Olympus

Provalis

Roche

Saliva Diagnostic

SeraCare

Siemens

Third Wave Technologies

Thermo Fisher

Tosho

Trinity Biotech

Tropix

Wampole Labs

Zenith

Zeus

List of Tables

Major Companies Developing or Marketing Enterovirus Tests

France